Skip to main content
KPTI $0.65 -3.07%
KPTI logo
KPTI · Karyopharm Therapeutics Inc.
Track KPTI — free
$0.65 -0.02 (-3.07%) At close · Oct 6
Market Cap
$36.74M
Shares
22.68M
Volume · Oct 6 1.18M Avg daily vol (3M) 1.68M
All webcasts

Earnings call · FY2024 Q2

Karyopharm Therapeutics Inc. (KPTI) Q2 2024 Earnings Call

Concluded Aug 6, 2024
Aug 6, 2024 0 turns
Period
FY2024 Q2
Runtime
—
Sources
2 artifacts

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Forward guidance

2 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $42.79M +13.9% YoY
Diluted EPS -$2.97
Net income $23.79M

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed Aug 6, 2024.

Metric Guided Actual
Total revenue Raised
full year 2024
$145M – $160M $145.24M within
U.S. XPOVIO net product revenue Raised
full year 2024
$105M – $120M —

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product$28.03M -1.5% YoY
License and Other$14.75M +61.8% YoY
Full-screen source Call document